lec7 pharmacodynamics Flashcards

1
Q

categories of drug effects

A

therapeutic
nontherapeutic
placebo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

dose intensity curves measures

A

how much effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

dose frequency curves measures

A

hoe many affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

application of the law of mass action to the kinetics of the binding of drug and receptor creates the equation

A

drug + receptor bound-receptor –> effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

dissociation constant (Kd) for the drug from the receptor is measured by (2 equations for it)

A

=Kr/Kf
K reverse / K forward
or
= drug + receptor / bound-receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the curve for durg conc v fraction of bound receptors (i.e. bound / total receptors) is what shape

A

hyperbolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the conc at which half of the receptors are bound is the

A

Kd = dissociation constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bmax is the

A

totality of the receptors bound by the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why are semilogarithmic plots used instead of linear (hyperbola)

A

linear plots at point near zero, the effect changes rapidly
semi log curve has large middle portion close to EC50 which is linear and easier to work with so easier to make accurate determination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Emax =

A

maximum effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is used as a measure of Kd

A

EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

lower EC50 means what to the affinity for binding to the receptor

A

lower EC50 –> lower Kd –> higher affinity for binding to the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drug conc producing an effect that’s 50% of the max effect

A

EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EC50 provides what important characteristic of drugs

A

potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Emax provides what important characteristic of drugs

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

define efficacy

A

max effect of a drug achieveable at a high dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

lower EC50 = ____ potency

A

higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

lower Emax = ____ efficacy

A

lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

when comparing 2 drugs you want the one with the lower or higher Emax

A

higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how well the drug binds the receptor

A

potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how well the drug produces the effect

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

t/f potency and efficacy are related

A

f: unrelated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

potency is ___ related to EC50

A

inversely

lower potency = higher EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ability of a drug to affect one tissue or receptor in prefereance to another

A

selectivity

25
Q

a highly selective drug is one which

A

affects only a receptor or tissue without affecting others

26
Q

what curve is needed to measure selectivity

A

concentration - response

27
Q

what type of agonist:

drug that has efficacy greater than zero but less than a full agonist

A

partial agonist

28
Q

what type of agonist:

drug that binds to a receptor and produces max bio response

A

full agonist

29
Q

what type of agonist:

drug that induces pharm response opposite of agonist

A

inverse agonist

30
Q

what is a neutral antagonist

A

drug that does NOT induce a bio response and reduces/blocks response induced by agonist

31
Q

order the 3 agonists from highest emax to lowest

A

full > partial > inverse

32
Q

process where a drug decr or opposes action of another drug or endogenous ligand

A

antagonism

33
Q

what are the 4 types of antagonisms

A

chemical
pharmacokinetic
physiological
pharmacological

34
Q

type of antagonism where antagonist accelerates the metabolism or the elimination of the agonist

A

pharmacokinetic

35
Q

type of antagonism where antagonist binds directly to agonistto make it inactive

A

chemical

36
Q

type of antagonism where theres 3 types

reversible competitive, noncompetitive, irreversible

A

pharmacological

37
Q

type of antagonismwhere antagonist activates a diff mechanism that opposes the effects of the agonist

A

physiological

38
Q

what happens to potency and efficacy in reversible competitive

A

right shift of dose-response curve
higher EC50 –> lower potency
no change in efficacy

39
Q

competitive antagonism can be overcome by

A

incr the conc of agonist to achieve the same effect as before

40
Q

can a noncompetitive antagonism be overcome

A

no cant restory to original response by incr conc of agonist

41
Q

what happens to potency and efficacy in noncompetitive

A

lower emax –> decr efficacy

unchanged potency

42
Q

what happens to potency and efficacy in irreversible competitive

A

lower emax –> decr effcacy

no change potency

43
Q

joint effect of 2 drugs is the sum of their individual effects

A

summation

44
Q

joint effect of 2 drugs is greater than sum of their effects

A

synergism

45
Q

inert drug enhances the effect of another drug

A

potentiation

46
Q

drug effect loss over time

A

tolerance

47
Q

mechanism for decreased effect (includes tachyphylaxis)

A

desensitization

48
Q

what curve is all or nothing i.e. their effect is scored on whether present or absent

A

quantal dose-response curves

49
Q

diff bn incremental and cumulative quantal curves

A

incremental - as dose incr, number responders incr (bell curve)
cumulative - as dose incr, number responders adds up

50
Q

which curve has more variability?
shallow, wider
taller, narrow

A

shallow, wide

51
Q

dose producing effect in 50% of subject

A

ED50

52
Q

dose making death in 50% of subjects

A

LD 50 = lethal dose

53
Q

what do different slopes in quantal curves imply

A

diff sources of variability, suggesting diff in route or mechanism of action

54
Q

therapeutic index equation

A

LD50 / ED50

55
Q

the higher the therapeutic index

A

the safer the drug

56
Q

why is pop variability important in quantal curves

A

bc can have same therapeutic index but different risk

57
Q

standardized safety margin equation

A

(LD1-ED99) / ED99 * 100

58
Q

the more positive the ED99 or the greater the diff bn LD1 and ED99 , the ___ the drug

A

safer